Böbreğin Diğer Onkositik Tümörleri
Özet
Eozinofilik/onkositik sitoplazmalı, onkositom ve kromofob RCC ile benzer özellikler aynı zamanda kendine has özellikler de içeren heterojen bir tümör grubudur. Yavaş seyir gösterdikleri için, net tanı vermekten ziyade, yüksek dereceli eozinofilik sitoplazmalı tümörlerden ayırt edilmesi önemlidir.
Referanslar
Guo J, Tretiakova MS, Troxell ML, Osunkoya AO, Fadare O, Sangoi AR, et al.Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 2014;38, 1457–1467
Trpkov K, Hes O. New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology 2019;74:31–59.
Akgul M, Al-Obaidy KI, Cheng L, et al. Low-grade oncocytic tumour expandsthe spectrum of renal oncocytic tumours and deserves separate classification:a review of 23 cases from a single tertiary institute. J Clin Pathol 2022;75:772–775.
Siadat, F. & Trpkov, K. ESC, ALK, HOT and LOT: Three letter acronyms of emerging renal entities knocking on the door of the who classification. Cancers 2021;12, 168.
WilliamsonSR,HesO,Trpkov K, et al.Low-grade oncocytictumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity. Histopathology 2023; 82:296–304.
Alghamdi M, Chen JF, Jungbluth A, Koutzaki S, Palmer MB, Al-Ahmadie HA, et al.. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma. Mod Pathol. 2024 ;37:100467
Morini A, Drossart T, Timsit MO, Sibony M, Vasiliu V, Gimenez-Roqueplo AP, et al. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and
low expression of FOXI1. Mod Pathol 2022;35, 352–360.
Kapur P, Gao M, Zhong H, Rakheja D, Cai Q, Pedrosa I, et al. EosinophilicVacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss. Adv Anat Pathol 2021;28, 251–257..
Lerma, L. A., Schade, G. R. & Tretiakova, M. S. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex. Hum. Pathol. 2021;116, 1–11.
Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, et al. Diagnostic criteria for oncocytic renal neoplasms:a survey of urologic pathologists. Human Pathology 2017; 63, 149–156.
He H, Trpkov K, Martinek P, et al. High-grade oncocytic renal tumor": morphologic immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch 2018;473:725–38.
Chen YB, Mirsadraei L, Jayakumaran G, et al. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm. Am J Surg Pathol 2019;43:121–31.
Trpkov K, Williamson SR, Gill AJ, et al. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 2021;34:1167–84.
Farcas M, Gatalica Z, Trpkov K, et al. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. Mod Pathol 2021;35:344-351
